Organizations Filed Purposes:
OUR MISSION IS SCIENTIFIC RESEARCH FOCUSING ON DEVELOPMENT OF PREVENTATIVE AND THERAPEUTIC TREATMENTS FOR BOTH INFECTIOUS (MALARIA, HEPATITIS B AND C, AND INFLUENZA) AND NON-INFECTIOUS DISEASES (CANCER AND CARDIOVASCULAR DISEASE).
DEVELOPMENT OF PRODUCTS TO TREAT AND/OR PREVENT VIRAL INFECTIONS & CERTAIN OTHER INFECTIOUS DISEASES.
OTHER VARIOUS R&D PROGRAMS/CONTRACTS
Research funded by the National Institute of Health to test a method to unambiguously identify correct isoform models for certain common mRNA splicing patterns in genes that encode mRNAs in multiple isoforms that current methods are unable to satisfactorly identify among alternative stuctures. A method of intoducing barcoded random primers in such a way that each mRNA molecule is exposed to one and only one barcode. This should produce molecule-specific collections of barcoded cDNA which should allow specific structural details of mRNA isoforms on a molecule by molecule basis, thus solving the isoform model identifiabilty problem.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| John Welsh Phd | CEO | 40 | $96,715 |
| Terry Dillman | Director | 1 | $0 |
| Randy Horton | Director | 1 | $0 |
| David R Milich Phd | Chairman | 2 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202022059349301482_public.xml